MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-Small Cell Lung Cancer Adenocarcinoma Patients

Journal of Cancer - Australia
doi 10.7150/jca.19254
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer

Journal of Clinical & Cellular Immunology
2014English

P2.16-43 Diabetes Is a Negative Prognostic Factor in Non-Small Cell Lung Cancer Patients Undergoing Resectional Surgery

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.03-31 Periostin Is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Prognostic Value of Number of Negative Lymph Node in Patients With Stage II and IIIa Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy